This was the stock's second consecutive day of gains.
The stock's fall snapped a three-day winning streak.
StockStory.org on MSN8h
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services StocksEarnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West ...
4d
Barchart on MSNIs West Pharmaceutical Services Stock Underperforming the S&P 500?Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures, and sells containment and delivery ...
West Pharmaceutical Services, Inc. has a 1-year low of $197.01 and a 1-year high of $400.88. The company has a market cap of $16.45 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio ...
Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products. With a market cap ...
West Pharmaceutical Services has a 1 year low of $197.01 and a 1 year high of $400.88. The company has a market capitalization of $16.95 billion, a price-to-earnings ratio of 35.04, a P/E/G ratio ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Proscia has raised $50 million in fresh capital, bringing the Center City digital pathology services company's total funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results